Want to see PRFX full AI Analyst Report?
PainReform (PRFX) Ratios
265 Followers
PainReform Ratios
PRFX's free cash flow for Q2 2026 was $-1.22M. For the 2026 fiscal year, PRFX's free cash flow was decreased by $-1.00K and operating cash flow was $-1.22M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.78 | 1.81 | 4.07 | 11.55 | 25.13 |
| Quick Ratio | 1.78 | 1.81 | 4.07 | 4.19 | 25.13 |
| Cash Ratio | 1.71 | 1.74 | 3.33 | 3.85 | 21.85 |
| Solvency Ratio | -1.50 | -5.40 | -3.47 | -6.72 | -7.30 |
| Operating Cash Flow Ratio | -1.62 | -5.17 | -2.77 | -6.07 | -8.66 |
| Short-Term Operating Cash Flow Coverage | -188.33 | -280.47 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.64M | $ 1.73M | $ 7.11M | $ 10.98M | $ 18.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.40 | 2.48 | 1.37 | 1.12 | 1.05 |
| Debt Service Coverage Ratio | -136.16 | -246.75 | -24.94 | -143.67 | -720.70 |
| Interest Coverage Ratio | -498.70 | -1048.07 | -24.96 | -145.39 | -720.80 |
| Debt to Market Cap | 0.01 | 0.15 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.05 | 3.25 | 8.62 | 1.37 | 0.24 |
| Net Debt to EBITDA | 0.98 | 0.29 | 0.83 | 0.47 | 2.30 |
| Profitability Margins | |||||
| Gross Profit Margin | -4864.71% | 0.00% | 0.00% | 82.56% | 0.00% |
| EBIT Margin | -29335.29% | 0.00% | 0.00% | -10197.67% | 0.00% |
| EBITDA Margin | -24782.35% | 0.00% | 0.00% | -10180.23% | 0.00% |
| Operating Profit Margin | -29335.29% | 0.00% | 0.00% | -10312.79% | 0.00% |
| Pretax Profit Margin | -29494.12% | 0.00% | 0.00% | -10212.79% | 0.00% |
| Net Profit Margin | -28458.82% | 0.00% | 0.00% | -10223.26% | 0.00% |
| Continuous Operations Profit Margin | -29541.18% | 0.00% | 0.00% | -10223.26% | 0.00% |
| Net Income Per EBT | 96.49% | 100.05% | 100.09% | 100.10% | 100.08% |
| EBT Per EBIT | 100.54% | 99.37% | 97.41% | 99.03% | 100.44% |
| Return on Assets (ROA) | -40.32% | -322.39% | -94.10% | -71.32% | -37.99% |
| Return on Equity (ROE) | -56.63% | -799.78% | -129.08% | -79.77% | -40.07% |
| Return on Capital Employed (ROCE) | -52.18% | -704.42% | -127.45% | -78.74% | -39.35% |
| Return on Invested Capital (ROIC) | -52.07% | -675.24% | -126.50% | -78.74% | -39.35% |
| Return on Tangible Assets | -109.78% | -322.39% | -94.10% | -71.32% | -37.99% |
| Earnings Yield | -232.60% | -4794.88% | -276.70% | -199.82% | -55.52% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.12 | 0.00 | 0.00 | 1.56 | 0.00 |
| Payables Turnover | 3.96 | 0.05 | 0.07 | 0.07 | 0.05 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.30 | 0.00 | 0.00 | 1.95 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Working Capital Turnover Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
| Cash Conversion Cycle | 2956.71 | -6752.50 | -5377.67 | 185507.43 | -7091.43 |
| Days of Sales Outstanding | 3048.82 | 0.00 | 0.00 | 233.43 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 190359.67 | 0.00 |
| Days of Payables Outstanding | 92.11 | 6752.50 | 5377.67 | 5085.67 | 7091.43 |
| Operating Cycle | 3048.82 | 0.00 | 0.00 | 190593.10 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.10 | -695.68 | -122.47 | -145.40 | -160.28 |
| Free Cash Flow Per Share | -6.11 | -696.40 | -122.63 | -145.54 | -161.51 |
| Dividend Paid and CapEx Coverage Ratio | -1977.50 | -970.85 | -742.11 | -1076.50 | -131.06 |
| Capital Expenditure Coverage Ratio | -1977.50 | -970.85 | -742.11 | -1076.50 | -131.06 |
| Operating Cash Flow Coverage Ratio | -188.33 | -280.47 | -77.66 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -232.65 | 0.00 | 0.00 | -75.10 | 0.00 |
| Free Cash Flow Yield | -190.24% | -4152.62% | -198.05% | -146.94% | -50.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.43 | -0.02 | -0.36 | -0.50 | -1.80 |
| Price-to-Sales (P/S) Ratio | 122.35 | 0.00 | 0.00 | 51.16 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.24 | 0.17 | 0.47 | 0.40 | 0.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.53 | -0.02 | -0.50 | -0.68 | -1.98 |
| Price-to-Operating Cash Flow Ratio | -0.53 | -0.02 | -0.51 | -0.68 | -1.99 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.03 | -0.04 | -0.02 |
| Enterprise Value Multiple | 0.49 | 0.27 | 0.48 | -0.03 | 0.48 |
| Enterprise Value | -2.07M | -3.91M | -4.56M | 303.90K | -3.49M |
| EV to EBITDA | 0.49 | 0.27 | 0.48 | -0.03 | 0.48 |
| EV to Sales | -121.47 | 0.00 | 0.00 | 3.53 | 0.00 |
| EV to Free Cash Flow | 0.52 | 0.31 | 0.68 | -0.05 | 0.53 |
| EV to Operating Cash Flow | 0.52 | 0.31 | 0.68 | -0.05 | 0.53 |
| Tangible Book Value Per Share | 2.62 | 100.54 | 132.73 | 248.10 | 442.28 |
| Shareholders’ Equity Per Share | 13.18 | 100.54 | 132.73 | 248.10 | 442.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.03 | 0.00 | 0.00 | 1.94 | 0.00 |
| Net Income Per Share | -7.47 | -804.10 | -171.33 | -197.92 | -177.23 |
| Tax Burden | 0.96 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.00 | 0.97 | 1.00 | 1.00 |
| Research & Development to Revenue | 66.82 | 0.00 | 0.00 | 51.42 | 0.00 |
| SG&A to Revenue | 177.88 | 0.00 | 0.00 | 51.71 | 0.00 |
| Stock-Based Compensation to Revenue | 26.29 | 0.00 | 0.00 | 16.15 | 0.00 |
| Income Quality | 0.79 | 0.87 | 0.71 | 0.73 | 0.90 |
Currency in USD
